Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK), is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer.
Member count: 11-50
Total raised: $25M
Founded date: 2000
Investors 1
| Date | Name | Website |
| - | Hercules C... | htgc.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 02.07.2018 | - | $25M | Hercules C... | citybizlis... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 10.03.2021 | Merrimack ... | CAMBRIDGE, Mass.--(BUSINESS WI... | - | - | oaoa.com/n... |
| 02.07.2018 | Merrimack ... | Merrimack Pharmaceuticals, Inc... | - | - | citybizlis... |